Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer (Q41344859)
scientific article published on December 1986
Language:
Current Data About Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer
(P31) (Q13442814)
(P248)
(P698) 3097903
(P813) Friday, September 29, 2017

(P50) (Q6283643)
(P1545) 3
(P1932) J H Burchenal
(P248)
(P698) 3097903
(P813) Friday, September 29, 2017

(P304) 508-511
(P248)
(P698) 3097903
(P813) Friday, September 29, 2017

(P407) (Q1860)

(P433) 6
(P248)
(P698) 3097903
(P813) Friday, September 29, 2017

(P478) 28
(P248)
(P698) 3097903
(P813) Friday, September 29, 2017

(P577) Monday, December 1, 1986
(P248)
(P698) 3097903
(P813) Friday, September 29, 2017

(P921) (Q5452194)

(P1433) (Q7900884)
(P248)
(P698) 3097903
(P813) Friday, September 29, 2017

(P1476) "Phase I trial of alpha-difluoromethyl ornithine (DFMO) and methylglyoxal bis (guanylhydrazone) (MGBG) in patients with advanced prostatic cancer" (language: en)
(P248)
(P698) 3097903
(P813) Friday, September 29, 2017

(P2093) H W Herr
(P1545) 1
(P248)
(P698) 3097903
(P813) Friday, September 29, 2017

R P Warrel
(P1545) 2
(P248)
(P698) 3097903
(P813) Friday, September 29, 2017

other details
description scientific article published on December 1986

External Links
(P356) 10.1016/0090-4295(86)90154-8
(P698) 3097903